Impact of baseline steroids on the efficacy of neoadjuvant immunochemotherapy in locally advanced esophageal squamous cell carcinoma

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 9

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Oncol. Sep 15, 2024; 16(9): 3887-3897
Published online Sep 15, 2024. doi: 10.4251/wjgo.v16.i9.3887

Table 2 Post-operation evaluation, n (%)

¹y indicates that the staging is done after neoadjuvant therapy; p indicates that the staging is based on pathological examination.

TNM: Tumor–node–metastasis; pCR: Complete pathological response; MPR: Major pathological response.

Citation: Huang YH, Yang GZ, Chen HG, Li XJ, Wu YH, Zhang K, Xu JN, Zhang J. Impact of baseline steroids on the efficacy of neoadjuvant immunochemotherapy in locally advanced esophageal squamous cell carcinoma. World J Gastrointest Oncol 2024; 16(9): 3887-3897
URL: https://www.wjgnet.com/1948-5204/full/v16/i9/3887.htm
DOI: https://dx.doi.org/10.4251/wjgo.v16.i9.3887

Huang YH, Yang GZ, Chen HG, Li XJ, Wu YH, Zhang K, Xu JN, Zhang J. Impact of baseline steroids on the efficacy of neoadjuvant immunochemotherapy in locally advanced esophageal squamous cell carcinoma. World J Gastrointest Oncol 2024; 16(9): 3887-3897 [PMID: 39350993 DOI: 10.4251/wjgo.v16.i9.3887]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.